banner
    LLY image

    Eli Lilly and Company

    LLY

    850.185

    USD
    +20.77
    (+2.50%)
    Day's range
    829.21
    854.34
    52 wk Range
    677.09
    972.53

    Key ratios

    P/E Ratio
    72.73
    Price/Book
    53.91
    Debt/Equity
    234.93%
    Return on equity
    77.11%
    Dividend Yield
    0.63%
    EBITDA
    15.23B

    Statements Highlights

    Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
    Total Revenue24,539,800,00028,318,400,00028,541,400,00034,124,100,00045,042,700,000
    Gross Profit19,056,500,00021,005,600,00021,911,600,00027,041,900,00036,624,400,001
    Operating Income6,441,000,0007,302,600,0008,653,300,00010,325,400,00017,501,700,000
    Net Income6,193,700,0005,581,700,0006,244,800,0005,240,400,00010,590,000,000
    Total Assets46,633,100,00048,806,000,00049,489,800,00064,006,300,00078,714,900,000
    Total Current Liabilities12,481,600,00015,052,700,00017,138,200,00027,293,200,00028,376,600,000
    Total Equity5,825,200,0009,154,800,00010,775,400,00010,863,700,00014,320,700,000
    Free Cash Flow4,470,500,0005,387,500,0004,600,400,000-3,152,000,000414,300,000
    Cash from Operations6,499,600,0007,365,900,0007,084,400,0004,240,100,0008,817,900,000
    Cash from Investing-2,258,900,000-2,762,300,000-3,261,600,000-7,152,700,000-9,301,500,000
    Cash from Financing-3,137,100,000-4,131,300,000-5,406,700,0003,495,600,0001,230,100,000
    Net Change in Cash1,319,600,000161,400,000-1,751,500,000751,600,000449,800,000

    Dividends

    Analyst Recomendations

    Overall consensus
    Buy